References
- van den Beuken-van EverdingenMHde RijkeJMKesselsAGSchoutenHCvan KleefMPatijnJPrevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnn Oncol2007181437144917355955
- PortenoyRKTreatment of cancer painLancet20113772236224721704873
- te BoveldtNVernooij-DassenMBurgerNIjsseldijkMVissersKEngelsYPain and its interference with daily activities in medical oncology outpatientsPain Physician20131637938923877454
- CaraceniAHanksGKaasaSUse of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCLancet Oncol201213e58e6822300860
- BennettMIGrahamJSchmidt-HansenMPrettyjohnsMArnoldSPrescribing strong opioids for pain in adult palliative care: summary of NICE guidanceBMJ2012344e280622623631
- BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician200811S105S12018443635
- TzschentkeTMChristophTKögelBYThe mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadolCNS Drugs20142831932924578192
- TaylorRPergolizziJVRaffaRBTapentadol extended release for chronic pain patientsAdv Ther201330142723328938
- MerkerMDingesGKochTKrankePMorinAMUndesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studiesSchmerz2012261626 German22366930
- SchwittayASchumannCLitzenburgerBSchwenkeKTapentadol prolonged release for severe chronic pain: results of a noninterventional study involving general practitioners and internistsJ Pain Palliat Care Pharmacother20132722523423957433
- StrohmeierMWaldmann-RexSSchwenkeKInfluence of tapentadol retard on functional parameters in patients with severe chronic pain – is there a benefit in daily life?MMW Fortschr Med20131556371 German24930324
- MercadanteSPorzioGFerreraPTapentadol in cancer pain management: a prospective open-label studyCurr Med Res Opin2012281775177923057488
- ImanakaKTominagaYEtropolskiMEfficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related painCurr Med Res Opin2013291399140923937387
- KressHGKochEDKosturskiHTapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related painPain Physician20141732934325054392
- MercadanteSPorzioGAdileCTapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer painCurr Med Res Opin2014302063206824926734
- ImanakaKTominagaYEtropolskiMOhashiHHiroseKMatsumuraTReady conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended releaseClin Drug Investig201434501511
- AgbalakaASchwenkeKLitzenburgerLTapentadol prolonged release for the treatment of severe chronic tumor pain in routine clinical practiceMMW Fortschr Med2012154123130 German23326931
- Grünenthal GmbHFachinformation Palexia® retard [German summary of product characteristics]Aachen, GermanyGrünenthal2010
- DworkinRHTurkDCFarrarJTCore outcome measures for chronic pain clinical trials: IMMPACT recommendationsPain200511391915621359
- KarnovskyDABurchenalJHThe clinical evaluation of chemotherapeutic agents in cancerMacLeodCMEvaluation of Chemotherapeutic AgentsNew YorkColumbia University Press1949196
- OkenMMCreechRHTormeyDCToxicity and response criteria of the Eastern Cooperative Oncology GroupAm J Clin Oncol198256496557165009
- EuroQoLHow to use EQ-5D Available from: http://www.euroqol.org/about-eq-5d/how-to-use-eq-5d.htmlAccessed May 15, 2014
- Deutsche SchmerzgesellschaftDeutscher Schmerzfragebogen [German pain questionnaire] Available from: http://www.dgss.org/deutscher-schmerzfragebogenAccessed May 15, 2014
- TaitRCChibnallJTKrauseSThe pain disability index: psychometric propertiesPain1990401711822308763
- BaslerHDThe Marburg questionnaire on habitual health findings – a study on patients with chronic painSchmerz199913385391 German12799914
- ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand1983673613706880820
- WareJJrKosinskiMKellerSDA 12-item short-form health survey: construction of scales and preliminary tests of reliability and validityMed Care1996342202338628042
- FrettlöhJMaierCGockelHHüppeMValidation of the German Mainz Pain Staging System in different pain syndromesSchmerz200317240251 German12923673
- SteigerwaldIMüllerMDaviesAEffectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b studyCurr Med Res Opin20122891193622443293